You are here: Industry Insights > Covaxin

News List

Bharat Biotech seeks full marketing approval from DCGI for Covaxin ExpressPharma
January 17, 2022
The company, however, is yet to submit the full follow up data of clinical trial of Covaxin to DCGI, a source said.
Covaxin booster neutralises Omicron and Delta variants of SARS-CoV-2: Study ExpressPharma
January 13, 2022
Hundred per cent of test serum samples showed neutralisation of the Delta variant and more than 90 per cent of serum samples showed neutralisation of the Omicron variant.
Covaxin booster dose study shows promising results ExpressPharma
January 10, 2022
Bharat Biotech recently announced the results from the highly anticipated trial studying the immunogenicity and safety of the Covaxin vaccine as a booster dose.
No paracetamol, painkillers recommended after Covaxin jab: Bharat Biotech ExpressPharma
January 07, 2022
No paracetamol or painkiller is recommended after being vaccinated with COVID-19 vaccine Covaxin, Bharat Biotech said yesterday.
India grants EUA to Bharat Biotech’s Covid-19 vaccine for use in children Pharmaceutical-Technology
December 28, 2021
The Drug Controller General of India (DGCI) has granted Emergency Use Authorization (EUA) to Bharat Biotech’s Covid-19 vaccine, Covaxin, for use in children aged 12 to 18 years.
Bharat Biotech seeks approval for Phase III intranasal Covid-19 vaccine trial Pharmaceutical-Technology
December 22, 2021
Indian company Bharat Biotech has filed an application with the Drugs Controller General of India (DCGI) seeking approval to commence Phase III clinical trial for its intranasal Covid-19 vaccine BBV154.
Bharat Biotech studying if Covaxin shot will work on Omicron expresspharma
December 02, 2021
Bharat Biotech said yesterday it was studying if its Covaxin shot would work against variants of coronavirus such as Omicron, after the CEO of drugmaker Moderna warned that the existing vaccines would be less effective.
Government gives nod to commercial export of Covishield and Covaxin in view of sufficient stock ExpressPharma
November 29, 2021
The Union government has allowed commercial export of Covishield and Covaxin considering the sufficient stock of the COVID-19 vaccines available with states and Union Territories as well as with manufacturers, official sources told PTI recently.
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study ExpressPharma
November 25, 2021
Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.
UK recognises Covaxin as valid COVID-19 vaccine for travel PharmaTimes
November 23, 2021
Travellers vaccinated with Bharat Biotech’s Covaxin will now be able to enter the UK, as the vaccine has been added to the approved list. This means that those inoculated with Covaxin...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page